Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2018-2029)
2.2 Exosome Therapy Growth Trends by Region
2.2.1 Global Exosome Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Exosome Therapy Historic Market Size by Region (2018-2024)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2024-2029)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Players by Revenue
3.1.1 Global Top Exosome Therapy Players by Revenue (2018-2024)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Revenue
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2022
3.5 Exosome Therapy Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Product Solution and Service
3.7 Date of Enter into Exosome Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2018-2024)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2024-2029)
5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2018-2024)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Exosome Therapy Market Size (2018-2029)
6.2 North America Exosome Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Exosome Therapy Market Size by Country (2018-2024)
6.4 North America Exosome Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapy Market Size (2018-2029)
7.2 Europe Exosome Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Exosome Therapy Market Size by Country (2018-2024)
7.4 Europe Exosome Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Market Size (2018-2029)
8.2 Asia-Pacific Exosome Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Exosome Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Exosome Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapy Market Size (2018-2029)
9.2 Latin America Exosome Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Exosome Therapy Market Size by Country (2018-2024)
9.4 Latin America Exosome Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Market Size (2018-2029)
10.2 Middle East & Africa Exosome Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Exosome Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Exosome Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Detail
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2018-2024)
11.1.5 United Therapeutics Corporation Recent Development
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Detail
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2018-2024)
11.2.5 Codiak BioSciences Recent Development
11.3 EngEx™
11.3.1 EngEx™ Company Detail
11.3.2 EngEx™ Business Overview
11.3.3 EngEx™ Exosome Therapy Introduction
11.3.4 EngEx™ Revenue in Exosome Therapy Business (2018-2024)
11.3.5 EngEx™ Recent Development
11.4 Esperite Group
11.4.1 Esperite Group Company Detail
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2018-2024)
11.4.5 Esperite Group Recent Development
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Detail
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2018-2024)
11.5.5 ArunA Biomedical Recent Development
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Detail
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.6.5 Evox Therapeutics Recent Development
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Detail
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2018-2024)
11.7.5 NeurExo Sciences Recent Development
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Detail
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2018-2024)
11.8.5 Tavec Pharmaceuticals Recent Development
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Detail
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.9.5 AEGLE Therapeutics Recent Development
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Detail
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2018-2024)
11.10.5 Avalon GloboCare Recent Development
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Detail
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2018-2024)
11.11.5 AlligatorBioscience Recent Development
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Detail
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.12.5 Capricor Therapeutics Recent Development
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Detail
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2018-2024)
11.13.5 Stem Cell Medicine Recent Development
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Detail
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.14.5 CellTex Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Exosome Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Direct Treatment
Table 3. Key Players of Drug Delivery Vehicle
Table 4. Global Exosome Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Exosome Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Exosome Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Exosome Therapy Market Share by Region (2018-2024)
Table 8. Global Exosome Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Exosome Therapy Market Share by Region (2024-2029)
Table 10. Exosome Therapy Market Trends
Table 11. Exosome Therapy Market Drivers
Table 12. Exosome Therapy Market Challenges
Table 13. Exosome Therapy Market Restraints
Table 14. Global Exosome Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Exosome Therapy Market Share by Players (2018-2024)
Table 16. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2022)
Table 17. Ranking of Global Top Exosome Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Exosome Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exosome Therapy Product Solution and Service
Table 21. Date of Enter into Exosome Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Exosome Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Exosome Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Exosome Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Exosome Therapy Revenue Market Share by Application (2018-2024)
Table 29. Global Exosome Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Exosome Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Exosome Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Exosome Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Exosome Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Exosome Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. United Therapeutics Corporation Company Detail
Table 47. United Therapeutics Corporation Business Overview
Table 48. United Therapeutics Corporation Exosome Therapy Product
Table 49. United Therapeutics Corporation Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 50. United Therapeutics Corporation Recent Development
Table 51. Codiak BioSciences Company Detail
Table 52. Codiak BioSciences Business Overview
Table 53. Codiak BioSciences Exosome Therapy Product
Table 54. Codiak BioSciences Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 55. Codiak BioSciences Recent Development
Table 56. EngEx™ Company Detail
Table 57. EngEx™ Business Overview
Table 58. EngEx™ Exosome Therapy Product
Table 59. EngEx™ Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 60. EngEx™ Recent Development
Table 61. Esperite Group Company Detail
Table 62. Esperite Group Business Overview
Table 63. Esperite Group Exosome Therapy Product
Table 64. Esperite Group Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 65. Esperite Group Recent Development
Table 66. ArunA Biomedical Company Detail
Table 67. ArunA Biomedical Business Overview
Table 68. ArunA Biomedical Exosome Therapy Product
Table 69. ArunA Biomedical Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 70. ArunA Biomedical Recent Development
Table 71. Evox Therapeutics Company Detail
Table 72. Evox Therapeutics Business Overview
Table 73. Evox Therapeutics Exosome Therapy Product
Table 74. Evox Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 75. Evox Therapeutics Recent Development
Table 76. NeurExo Sciences Company Detail
Table 77. NeurExo Sciences Business Overview
Table 78. NeurExo Sciences Exosome Therapy Product
Table 79. NeurExo Sciences Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 80. NeurExo Sciences Recent Development
Table 81. Tavec Pharmaceuticals Company Detail
Table 82. Tavec Pharmaceuticals Business Overview
Table 83. Tavec Pharmaceuticals Exosome Therapy Product
Table 84. Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 85. Tavec Pharmaceuticals Recent Development
Table 86. AEGLE Therapeutics Company Detail
Table 87. AEGLE Therapeutics Business Overview
Table 88. AEGLE Therapeutics Exosome Therapy Product
Table 89. AEGLE Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 90. AEGLE Therapeutics Recent Development
Table 91. Avalon GloboCare Company Detail
Table 92. Avalon GloboCare Business Overview
Table 93. Avalon GloboCare Exosome Therapy Product
Table 94. Avalon GloboCare Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 95. Avalon GloboCare Recent Development
Table 96. AlligatorBioscience Company Detail
Table 97. AlligatorBioscience Business Overview
Table 98. AlligatorBioscience Exosome Therapy Product
Table 99. AlligatorBioscience Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 100. AlligatorBioscience Recent Development
Table 101. Capricor Therapeutics Company Detail
Table 102. Capricor Therapeutics Business Overview
Table 103. Capricor Therapeutics Exosome Therapy Product
Table 104. Capricor Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 105. Capricor Therapeutics Recent Development
Table 106. Stem Cell Medicine Company Detail
Table 107. Stem Cell Medicine Business Overview
Table 108. Stem Cell Medicine Exosome Therapy Product
Table 109. Stem Cell Medicine Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 110. Stem Cell Medicine Recent Development
Table 111. CellTex Therapeutics Company Detail
Table 112. CellTex Therapeutics Business Overview
Table 113. CellTex Therapeutics Exosome Therapy Product
Table 114. CellTex Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 115. CellTex Therapeutics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapy Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Exosome Therapy Market Share by Type: 2022 VS 2029
Figure 3. Direct Treatment Features
Figure 4. Drug Delivery Vehicle Features
Figure 5. Global Exosome Therapy Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Exosome Therapy Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Exosome Therapy Report Years Considered
Figure 11. Global Exosome Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Exosome Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Exosome Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Exosome Therapy Market Share by Players in 2022
Figure 15. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Exosome Therapy Revenue in 2022
Figure 17. North America Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Exosome Therapy Market Share by Country (2018-2029)
Figure 19. United States Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Exosome Therapy Market Share by Country (2018-2029)
Figure 23. Germany Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Exosome Therapy Market Share by Region (2018-2029)
Figure 31. China Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Exosome Therapy Market Share by Country (2018-2029)
Figure 39. Mexico Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Exosome Therapy Market Share by Country (2018-2029)
Figure 43. Turkey Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. United Therapeutics Corporation Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 46. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 47. EngEx™ Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 48. Esperite Group Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 49. ArunA Biomedical Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 50. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 51. NeurExo Sciences Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 52. Tavec Pharmaceuticals Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 53. AEGLE Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 54. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 55. AlligatorBioscience Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 56. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 57. Stem Cell Medicine Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 58. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed